Brief Suicide & Trauma Therapy for Suicide Risk (BSTT Trial)

N/A

Waitlist Available

Led By Sakina Rizvi, PhD,MACP,RP

Research Sponsored by Unity Health Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from baseline to 12-weeks. also re-assessed at 3 months post-intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a combined therapy to reduce suicide risk in people with a history of childhood trauma.

Who is the study for?

This trial is for individuals who can communicate in English, have any psychiatric diagnosis, and show significant suicidal thoughts measured by a specific scale. They must be able to consent to treatment, not be in other psychotherapy programs, and have experienced childhood trauma as defined by a questionnaire.

What is being tested?

The study tests Brief Suicide and Trauma Therapy (BSTT), which combines coping skills enhancement with trauma therapy aimed at reducing suicide risk due to childhood trauma. Participants will undergo this integrated intervention over a period of 12 weeks.

What are the potential side effects?

While the trial focuses on psychotherapy without medication, side effects may include emotional discomfort or distress related to discussing traumatic experiences or confronting difficult emotions during therapy sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from baseline to 12-weeks. also re-assessed at 3 months post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from baseline to 12-weeks. also re-assessed at 3 months post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 12-weeks. also re-assessed at 3 months post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in suicidal ideation using Beck Scale for Suicide Ideation

Secondary study objectives

Change in anxiety symptoms using the Generalized Anxiety Disorder 7-item scale (GAD-7)

Change in attachment security using the Experience in Close Relationships 12-item scale (ECR)

Change in coping strategies using the Brief-Coping Orientation to Problems Experienced (Brief-COPE)

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Brief Suicide and Trauma Therapy (BSTT)Experimental Treatment1 Intervention

This novel suicide intervention integrates Brief Skills for Safer Learning (B-SfSL) with trauma therapy. BSTT incorporates the guiding principles of taking a non-pathologizing approach to treatment, emphasizing safety, attending to the therapeutic relationship, empowering clients, and incorporating solution-focused concepts.

Do I qualify?Apply below to find out